Beckman Research Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2021

  1. Long-term efficacy and safety of CT-P10 or rituximab in untreated advanced follicular lymphoma: A randomized phase 3 study

    Blood Advances, Vol. 5, Núm. 17, pp. 3354-3361

2017

  1. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial

    The Lancet Haematology, Vol. 4, Núm. 8, pp. e362-e373